Effect of AT 1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction

Respiratory Physiology and Neurobiology

Volumn 183, Issue 2, 2012, Pages 67-74

  Marcus, Noah J ^a   Philippi, Nathan R ^a   Bird, Cynthia E ^a   Li, Yu Long ^b   Schultz, Harold D ^b   Morgan, Barbara J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Endothelial function; Intermittent hypoxia

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; NITROPRUSSIDE SODIUM; SUPEROXIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE FLUCTUATION; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; INTRACELLULAR SIGNALING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION; ANIMAL; ANOXIA; ARTERY; BIOSYNTHESIS; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ACETYLCHOLINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANOXIA; ARTERIES; ENDOTHELIUM, VASCULAR; LOSARTAN; MALE; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SIGNAL TRANSDUCTION; SUPEROXIDES; VASCULAR RESISTANCE; VASODILATION;

EID: 84864328415     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.05.025     Document Type: Article

References (55)

1. Allahdadi K.J., Walker B.R., Kanagy N.L. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005, 45:705-709.
2. Bao G., Metreveli N., Fletcher E.C. Acute and chronic blood pressure response to recurrent acoustic arousal in rats. American Journal of Hypertension 1999, 12:504-510.
3. Boger R.H., Ron E.S. l-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. Alternative Medicine Review 2005, 10:14-23.
4. Bradley T.D., Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009, 373:82-93.
5. Brooks D., Horner R.L., Kozar L.F., Render-Teixeira C.L., Phillipson E.A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. Journal of Clinical Investigation 1997, 99:106-109.
6. Cersosimo E., DeFronzo R.A. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes/Metabolism Research and Reviews 2006, 22:423-436.
7. Chen M.F., Xie X.M., Yang T.L., Wang Y.J., Zhang X.H., Luo B.L., Li Y.J. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II. Journal of Vascular Research 2007, 44:391-402.
8. Cosentino F., Rubattu S., Savoia C., Venturelli V., Pagannonne E., Volpe M. Endothelial dysfunction and stroke. Journal of Cardiovascular Pharmacology 2001, 38(Suppl. 2):S75-S78.
9. Cross M.D., Mills N.L., Al-Abri M., Riha R., Vennelle M., Mackay T.W., Newby D.E., Douglas N.J. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 2008, 63:578-583.
10. Fletcher E.C., Bao G., Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999, 34:309-314.
11. Fletcher E.C., Bao G., Miller C.C. Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. Journal of Applied Physiology 1995, 78:1516-1521.
12. Fletcher E.C., Lesske J., Behm R., Miller C.C., Stauss H., Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. Journal of Applied Physiology 1992, 72:1978-1984.
13. Fletcher E.C., Lesske J., Culman J., Miller C.C., Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 1992, 20:612-619.
14. Fletcher E.C., Lesske J., Qian W., Miller C.C., Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992, 19:555-561.
15. Foster G.E., Hanly P.J., Ahmed S.B., Beaudin A.E., Pialoux V., Poulin M.J. Intermittent hypoxia increases arterial blood pressure in humans through a renin-angiotensin system-dependent mechanism. Hypertension 2010, 56(3):369-377.
16. Grote L., Kraiczi H., Hedner J. Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine 2000, 162:1480-1487.
17. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
18. Imadojemu V.A., Gleeson K., Quraishi S.A., Kunselman A.R., Sinoway L.I., Leuenberger U.A. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. American Journal of Respiratory and Critical Care Medicine 2002, 165:950-953.
19. Ip M.S., Tse H.F., Lam B., Tsang K.W., Lam W.K. Endothelial function in obstructive sleep apnea and response to treatment. American Journal of Respiratory and Critical Care Medicine 2004, 169:348-353.
20. Kanagy N.L., Walker B.R., Nelin L.D. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001, 37:511-515.
21. Kato M., Roberts-Thomson P., Phillips B.G., Haynes W.G., Winnicki M., Accurso V., Somers V.K. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102:2607-2610.
22. Kraiczi H., Hedner J., Peker Y., Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. Journal of Applied Physiology 2000, 89:493-498.
23. Lattimore J.L., Wilcox I., Skilton M., Langenfeld M., Celermajer D.S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006, 61:491-495.
24. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997, 95:588-593.
25. Loot A.E., Schreiber J.G., Fisslthaler B., Fleming I. Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. Journal of Experimental Medicine 2009, 206:2889-2896.
26. Luscher T.F. The endothelium in hypertension: bystander, target or mediator?. Journal of Hypertension Supplement 1994, 12:S105-S116.
27. Marcus N.J., Li Y.L., Bird C.E., Schultz H.D., Morgan B.J. Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respiratory Physiology and Neurobiology 2010, 171:36-45.
28. Marcus N.J., Olson E.B., Bird C.E., Philippi N.R., Morgan B.J. Time-dependent adaptation in the hemodynamic response to hypoxia. Respiratory Physiology and Neurobiology 2009, 165:90-96.
29. Marcus N.J., Philippi N.R., Bird C.E., Schultz H.D., Li Y., Morgan B.J. Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction. FASEB Journal 2010, 24. 1022.7.
30. Moller D.S., Lind P., Strunge B., Pedersen E.B. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. American Journal of Hypertension 2003, 16:274-280.
31. Paravicini T.M., Touyz R.M. Redox signaling in hypertension. Cardiovascular Research 2006, 71:247-258.
32. Peng Y.J., Nanduri J., Yuan G., Wang N., Deneris E., Pendyala S., Natarajan V., Kumar G.K., Prabhakar N.R. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. Journal of Neuroscience 2009, 29:4903-4910.
33. Peng Y.J., Overholt J.L., Kline D., Kumar G.K., Prabhakar N.R. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:10073-10078.
34. Peng Y.J., Yuan G., Jacono F.J., Kumar G.K., Prabhakar N.R. 5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase. Journal of Physiology 2006, 576:289-295.
35. Peng Y.J., Yuan G., Ramakrishnan D., Sharma S.D., Bosch-Marce M., Kumar G.K., Semenza G.L., Prabhakar N.R. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. Journal of Physiology 2006, 577:705-716.
36. Pepin J.L., Tamisier R., Barone-Rochette G., Launois S.H., Levy P., Baquet J.P. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. American Journal of Respiratory and Critical Care Medicine 2010, 182(7):954-960.
37. Philippi N.R., Bird C.E., Marcus N.J., Olson E.B., Chesler N.C., Morgan B.J. Time course of intermittent hypoxia-induced impairments in resistance artery structure and function. Respiratory Physiology and Neurobiology 2010, 170:157-163.
38. Phillips S.A., Olson E.B., Lombard J.H., Morgan B.J. Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. Journal of Applied Physiology 2006, 100:1117-1123.
39. Phillips S.A., Olson E.B., Morgan B.J., Lombard J.H. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. American Journal of Physiology: Heart and Circulatory Physiology 2004, 286:H388-H393.
40. Pialoux V., Hanly P.J., Foster G.E., Brugniaux J.V., Beaudin A.E., Hartmann S.E., Pun M., Duggan C.T., Poulin M.J. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans. American Journal of Respiratory and Critical Care Medicine 2009, 180(10):1002-1009.
41. Polotsky V.Y., Rubin A.E., Balbir A., Dean T., Smith P.L., Schwartz A.R., O'Donnell C.P. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Medicine 2006, 7:7-16.
42. Porrello E.R., Delbridge L.M., Thomas W.G. The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Frontiers in Bioscience 2009, 14:958-972.
43. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., Resnick H.E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. American Journal of Epidemiology 2004, 160:521-530. Sleep Heart Health Study Investigators.
44. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Journal of Clinical Investigation 1996, 97:1916-1923.
45. Schiffrin E.L. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. American Journal of Hypertension 2004, 17:1192-1200.
46. Schulman I.H., Zhou M-S., Raij L. Cross-talk between angiotensin II receptor types 1 and 2, potential role in vascular remodeling in humans. Hypertension 2007, 49:270-271.
47. Sica A.L., Greenberg H.E., Ruggiero D.A., Scharf S.M. Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Respiration Physiology 2000, 121:173-184.
48. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. Journal of Clinical Investigation 1995, 96:1897-1904.
49. Sullivan J.A., Rupnow H.L., Cale J.M., Magness R.R., Bird I.M. Pregnancy and ovarian steroid regulation of angiotensin II type 1 and type 2 receptor expression in ovine uterine artery endothelium and vascular smooth muscle. Endothelium 2005, 12:41-56.
50. Tahawi Z., Orolinova N., Joshua I.G., Bader M., Fletcher E.C. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. Journal of Applied Physiology 2001, 90:2007-2013. discussion 2000.
51. Troncoso Brindeiro C.M., da Silva A.Q., Allahdadi K.J., Youngblood V., Kanagy N.L. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. American Journal of Physiology: Heart and Circulatory Physiology 2007, 293:H2971-H2976.
52. Vanhoutte P.M. Endothelial dysfunction in hypertension. Journal of Hypertension Supplement 1996, 14:S83-S93.
53. Versari D., Daghini E., Virdis A., Ghiadoni L., Taddei S. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. British Journal of Pharmacology 2009, 157:527-536.
54. Weaver T.E., Grunstein R.R. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proceedings of the American Thoracic Society 2008, 5:173-178.
55. Yuan Z.M., Chen B.Y., Wang P.X., Li S.Y., Chen Y.L., Dong L.X. Changes of angiotensin II and its receptor during the development of chronic intermittent hypoxia-induced hypertension in rats. Zhonghua Jie He He Hu Xi Za Zhi 2004, 27:577-580.